Dexcom DXCM
NASDAQ DXCM
$83.88 -0.65 (-0.77%)
At close: Sep 9, 2026 · 4:00 PM EDT

Dexcom (DXCM) Long-Term Debt Issuances (2010 - 2018)

Dexcom's (DXCM) quarterly Long-Term Debt Issuances came in at $836.6 million in Q4 2018, up 1215.47% quarter-over-quarter from -$75.0 million in Q3 2017.

Analysis

Dexcom (DXCM) Long-Term Debt Issuances (2010 - 2018) Analysis & Trends

Dexcom (DXCM) has reported Long-Term Debt Issuances for 5 consecutive years, with $836.6 million the latest figure, recorded in Q4 2018.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $836.6 million in Q4 2018; TTM through Sep 2020 was $836.6 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $1.2 billion, changed N/A from the prior year.
  • Long-Term Debt Issuances was $836.6 million for Q4 2018 at Dexcom, up from -$75.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $836.6 million in Q4 2018 and troughed at -$75.0 million in Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -33.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 11.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 836.60 Mn
Sep 30, 2017 -75.00 Mn
Jun 30, 2017 389.00 Mn
Mar 31, 2017 75.00 Mn
Dec 31, 2012 6.60 Mn
Dec 31, 2011 -25,000.00
Sep 30, 2011 75,000.00
Jun 30, 2011 225,000.00
Mar 31, 2011 225,000.00
Dec 31, 2010 225,000.00
Sep 30, 2010 225,000.00